RESEARCH 61
FURTHER READING
Dhesi JK, Allain TJ, Mangoni AA, Jackson SHD. The implications of a
growing evidence base for drug use in elderly patients. Part 4.
Vitamin D and bisphosphonates for fractures and osteoporosis.
British Journal of Clinical Pharmacology2006; 61 : 520–8.
Hanratty CG, McGlinchey P, Johnston GD, Passmore AP. Differential
pharmacokinetics of digoxin in elderly patients. Drugs and Aging
2000; 17 : 353–62.
Mangoni AA, Jackson SHD. The implications of a growing evidence
base for drug use in elderly patients. Part 1. Statins for primary
and secondary cardiovascular prevention. British Journal of Clinical
Pharmacology2006; 61 : 494–501.
Mangoni AA, Jackson SHD. The implications of a growing evidence
base for drug use in elderly patients. Part 2. ACE inhibitors and
angiotensin receptor blockers in heart failure and high cardiovas-
cular risk patients. British Journal of Clinical Pharmacology2006; 61 :
502–12.
Mangoni AA, Jackson SHD. The implications of a growing evidence
base for drug use in elderly patients. Part 3. β-adrenoceptor block-
ers in heart failure and thrombolytics in acute myocardial infarc-
tion.British Journal of Clinical Pharmacology2006; 61 : 513–20.
Sproule BA, Hardy BG, Shulman KI. Differential pharmacokinetics in
elderly patients. Drugs and Aging2000; 16 : 165–77.